1-3 of 3
Monika Brüggemann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Standardized MRD Flow and ASO IGH RQ-PCR for MRD Quantification in CLL Patients after Rituximab-Containing Immunochemotherapy – a Comparative Analysis in 574 Samples from the Randomized GCLLSG CLL8 Trial

Sebastian Boettcher, MD, Stephan Stilgenbauer, MD, PhD, Raymonde Busch, Monika Brüggemann, MD, PhD, Thorsten Raff, MD, Kirsten Fischer, MD, Günter Fingerle-Rowson, MD, PhD, Anna-Maria Fink, MD, Christiane Pott, MD, Hartmut Döhner, MD, PhD, Michael Hallek, MD, PhD, Michael Kneba, MD, PhD, Matthias Ritgen, MD, on Behalf Of GCLLSG
Journal: Blood
Blood (2008) 112 (11): 3139.
https://doi.org/10.1182/blood.V112.11.3139.3139
Published: 2008
Journal Articles

MRD Kinetics in Adult Transplantation Recipients with Relapsed Acute Lymphoblastic Leukemia Depend on Initial Molecular Response to Front-Line Chemotherapy.

Monika Brüggemann, MD, Thorsten Raff, MD, Christiane Pott, MD, Sebastian Böttcher, MD, Matthias Ritgen, MD, Renate Arnold, MD, Dieter Hoelzer, MD, Nicola Goekbuget, MD, Michael Kneba, MD
Journal: Blood
Blood (2007) 110 (11): 2799.
https://doi.org/10.1182/blood.V110.11.2799.2799
Published: 2007
Journal Articles

Measurement of Minimal Residual Disease (MRD) after Consolidation Therapy as a Means of Early Detection of Relapse in Adult Acute Lymphoblastic Leukemia (ALL).

Michael Kneba, MD, PhD, Monika Brüggemann, MD, Nicola Gökbuget, MD, Regina Reutzel, Dieter Hoelzer, MD, PhD, Thorsten Raff, MD
Journal: Blood
Blood (2005) 106 (11): 538.
https://doi.org/10.1182/blood.V106.11.538.538
Published: 2005